X4 Pharmaceuticals, Inc (XFOR) stock
XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.09+0.26 (+9.19%)
Close on Nov 17, 2026Market cap $306.36MP/E –Yield –
X4 Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
X4 Pharmaceuticals's price to book ratio was 2.0× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 0.4× to 163.7×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.0× | +0.4 |
| 2025 | Dec 31, 2025 | 1.6× | −0.4 |
| 2024 | Dec 31, 2024 | 2.1× | +0.0 |
| 2023 | Dec 29, 2023 | 2.0× | +0.9 |
| 2022 | Dec 30, 2022 | 1.1× | +0.3 |
| 2021 | Dec 31, 2021 | 0.8× | −0.3 |
| 2020 | Dec 31, 2020 | 1.2× | −0.5 |
| 2019 | Dec 31, 2019 | 1.7× | – |
See a number that looks wrong?